KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $653.0 million.

  • Amgen's Interest Expenses fell 1258.37% to $653.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year decrease of 1267.83%. This contributed to the annual value of $2.8 billion for FY2025, which is 1267.83% down from last year.
  • Amgen's Interest Expenses amounted to $653.0 million in Q4 2025, which was down 1258.37% from $685.0 million recorded in Q3 2025.
  • Over the past 5 years, Amgen's Interest Expenses peaked at $824.0 million during Q1 2024, and registered a low of $281.0 million during Q2 2021.
  • For the 5-year period, Amgen's Interest Expenses averaged around $569.4 million, with its median value being $669.0 million (2025).
  • As far as peak fluctuations go, Amgen's Interest Expenses plummeted by 1763.01% in 2021, and later skyrocketed by 12926.83% in 2023.
  • Over the past 5 years, Amgen's Interest Expenses (Quarter) stood at $335.0 million in 2021, then grew by 23.88% to $415.0 million in 2022, then surged by 97.83% to $821.0 million in 2023, then fell by 9.01% to $747.0 million in 2024, then fell by 12.58% to $653.0 million in 2025.
  • Its Interest Expenses was $653.0 million in Q4 2025, compared to $685.0 million in Q3 2025 and $694.0 million in Q2 2025.